Low Testosterone Linked to Higher Complications After Hip and Knee Replacement Surgery

A groundbreaking study reveals that men with testosterone deficiency face substantially higher risks of complications following hip and knee replacement surgeries, potentially impacting millions of aging males who undergo these procedures annually.

Researchers analyzed data from over 280,000 male patients across 95 healthcare organizations, comparing surgical outcomes between men with testosterone deficiency (below 300 ng/dL) and those with normal levels. The study excluded patients receiving testosterone replacement therapy to isolate the effects of untreated hormone deficiency.

Using sophisticated propensity score matching to control for demographics and health conditions, scientists tracked complications for up to two years post-surgery. Results showed distinct patterns: hip replacement patients with low testosterone experienced significantly more blood clots and pulmonary embolisms. Knee replacement patients faced even broader complications, including higher rates of joint loosening, manipulation procedures, readmissions, and revision surgeries, though interestingly showed lower infection rates.

These findings have profound implications for healthy aging and surgical planning. Testosterone plays crucial roles in bone density, muscle mass, and healing processes—all critical for successful joint replacement recovery. The research suggests that addressing hormone deficiency before surgery could potentially reduce complications and improve long-term outcomes. For the growing population of active older adults seeking to maintain mobility through joint replacement, optimizing hormonal health may be as important as traditional pre-surgical preparations. However, the study's observational nature means causation cannot be definitively established, and individual patient factors must always guide treatment decisions.